IP
InvestPlatform
Private investment marketplace
Sign in

Founder case

Genetix Innovations

Emily Carter · Global · May 29, 2026

Back to founder cases
Biotech Global Requested capital: $180,000

Overview

At Genetix Innovations, we are pioneering a novel approach to gene editing that significantly enhances precision and reduces risks associated with genetic modifications. Our team, comprising experts from leading biotech firms and top universities, has developed a proprietary platform that enables targeted editing of complex genomes in both plant and animal species. This innovative technology holds immense potential for various applications, including agriculture, medicine, and environmental conservation. To date, we have successfully completed Phase 1 of our research, securing promising early results that demonstrate the efficacy and safety of our gene-editing methods. We have also established partnerships with several academic institutions, allowing us to leverage their facilities and resources for further experimentation. However, to move forward and begin Phase 2, we require additional funding. The biotech field is fiercely competitive, and securing the necessary investment will ensure we can maintain momentum and stay ahead of potential competitors while refining our product for commercial application. I am looking for a financial partner who can help turn this plan into a stab…

Use of funds

The $180,000 will be allocated as follows:

  • R&D Expenses: $100,000 for advancing our research, including laboratory materials and specialized equipment.
  • Regulatory Compliance: $40,000 to navigate the complex regulatory landscape and ensure our technology meets all necessary guidelines.
  • Operational Costs: $30,000 to cover salaries for critical team members during the initial development phase and other overhead expenses.

Open case

Open this case to get the detailed business plan and direct contact with the founder or seeker.